ICD-10 Coding for Creatine Phosphokinase(R79.89, M62.82)
Complete ICD-10-CM coding and documentation guide for Creatine Phosphokinase. Includes clinical validation requirements, documentation requirements, and coding pitfalls.
Also known as:
Related ICD-10 Code Ranges
Complete code families applicable to Creatine Phosphokinase
R79.89Primary Range
Other specified abnormal findings of blood chemistry
Used for elevated CPK levels when the cause is unknown or non-specific.
Long term (current) use of hormonal contraceptives
Used to indicate statin use when elevated CPK is related to medication.
Code Comparison: When to Use Each Code
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| R79.89 | Other specified abnormal findings of blood chemistry | Use when elevated CPK is the primary concern and the cause is not specified. |
|
| M62.82 | Rhabdomyolysis | Use when there is evidence of muscle breakdown. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information: ICD-10 code for elevated CPK
Essential facts and insights about Creatine Phosphokinase
Primary ICD-10-CM Codes for creatine phosphokinase
Decision Criteria
clinical Criteria
- CPK >3x ULN with myalgia
Applicable To
- Elevated CPK
Excludes
- Rhabdomyolysis (M62.82)
Clinical Validation Requirements
- CPK >3x ULN with symptoms such as myalgia
Code-Specific Risks
- Overcoding without proper documentation of symptoms
Coding Notes
- Ensure documentation includes symptoms and lab values.
M62.82 - Rhabdomyolysis
Use when there is evidence of muscle breakdown.
Applicable To
- Muscle breakdown
Excludes
- Muscle strain (M62.81)
Clinical Validation Requirements
- CPK >1,000 U/L with myoglobinuria
Coding Notes
Document muscle injury and lab findings.
Ancillary Codes
Additional codes that should be used in conjunction with the main diagnosis codes when applicable.
Long term (current) use of hormonal contraceptives
Z79.3Documentation & Coding Risks
Avoid these common documentation and coding issues when documenting Creatine Phosphokinase to ensure proper reimbursement, maintain compliance, and reduce audit risk. These guidelines are particularly important when using ICD-10 code R79.89.
Impact
Clinical: Incomplete clinical picture, Regulatory: Non-compliance with coding guidelines, Financial: Potential claim denials
Mitigation Strategy
Ensure symptoms are documented with lab results, Use templates to guide documentation
Impact
Reimbursement: Potential denial of claims, Compliance: Increased audit risk, Data Quality: Inaccurate clinical data
Mitigation Strategy
Ensure documentation links elevated CPK to a specific condition or medication.
Impact
Risk of audits due to lack of detailed documentation linking CPK to symptoms or causes.
Mitigation Strategy
Use detailed templates and ensure all relevant information is documented.
Documentation errors, coding pitfalls, and audit risks are interconnected aspects of medical coding and billing. Addressing all three areas helps ensure accurate coding, optimal reimbursement, and regulatory compliance.
Frequently Asked Questions
Common questions about ICD-10 coding for Creatine Phosphokinase, with expert answers to help guide accurate code selection and documentation.
Documentation Templates for Creatine Phosphokinase
Use these documentation templates to ensure complete and accurate documentation for Creatine Phosphokinase. These templates include all required elements for proper coding and billing.
Statin-induced myopathy
Specialty: CardiologyRequired Elements
- Patient history
- Medication list
- CPK levels
- Symptoms
Example Documentation
Examples: Poor vs. Good Documentation
Poor Documentation Example
Good Documentation Example
Explanation
Need help with ICD-10 coding for Creatine Phosphokinase? Ask your questions below.